Tissue microarrays for high-throughput molecular profiling of tumor specimens

Nature Medicine

Volumn 4, Issue 7, 1998, Pages 844-847

  Kononen, Juha ^a   Bubendorf, Lukas ^b   Kallioniemi, Anne ^a   Bärlund, Maarit ^c   Schraml, Peter ^b   Leighton, Stephen ^d   Torhorst, Joachim ^b   Mihatsch, Michael J ^b   Sauter, Guido ^b   Kallioniemi, Olli P ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF BASEL   (Switzerland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d Beecher Instruments   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; DNA DETERMINATION; GENE AMPLIFICATION; GENETIC SCREENING; HUMAN; HUMAN TISSUE; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN TARGETING;

ANIMALS; BREAST NEOPLASMS; CYCLIN D1; FEMALE; GENETIC TECHNIQUES; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU HYBRIDIZATION, FLUORESCENCE; MICE; ONCOGENE PROTEINS V-MYB; PROTO-ONCOGENE PROTEINS C-MYC; RABBITS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RETROVIRIDAE PROTEINS, ONCOGENIC; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031822837     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0798-844     Document Type: Article

References (20)

1. DeRisi, J. et al. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nature Genet. 14, 457-460 (1996).
2. Zhang, L. et al. Gene expression profiles in normal and cancer cells. Science 276, 1268-1272 (1997).
3. Kallioniemi, O.P. et al. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc. Natl. Acad. Sci. USA. 89, 5321-5325 (1992).
4. Ried, T. Interphase cytogenetics and its role in molecular diagnostics of solid tumors. Am. J. Pathol. 152, 325-328 (1998).
5. Pauletti, G., Godolphin, W., Press, M.F. & Slamon, D.J. Detection and quantitation of HER-2/neu gene amplification in human breastcancer archival material using fluorescence in situ hybridization. Oncogene 13, 63-72 (1996).
6. Slamon, D.J. et al. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244, 707-712 (1989).
7. Barbareschi, M. et al. Cyclin-D1-gene amplification and expression in breast carcinoma: relation with clinicopathologic characteristics and with retinoblastoma gene product, p53 and p21WAF1 immunohistochemical expression. Int. J. Cancer 74, 171-174 (1997).
8. Persons, D.L., Borelli, K.A. & Hsu, P.H. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization. Mod. Pathol. 10, 720-727 (1997).
9. Guan, X.Y., Meltzer, P.S., Dalton, W.S & Trent, J.M. Identification of cryptic sites of DNA sequence amplification in human breast cancer by chromosome microdissection. Nature Genet. 8, 155-161 (1994).
10. Muleris, M., Almeida, A., Gerbault-Seureau, M., Malfoy, B. & Dutrillaux, B. Detection of DNA amplification in 17 primary breast carcinomas with homogeneously staining regions by a modified comparative genomic hybridization technique. Genes Chrom. Cancer 10, 160-170 (1994).
11. Barlund, M. et al. Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions. Genes Chrom. Cancer 20, 372-376 (1997).
12. Tanner, M.M. et al. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res. 54, 4257-4260 (1994).
13. Noben-Trauth, K. et al. Mybl2 (Bmyb) maps to mouse chromosome 2 and human chromosome 20q13.1. Genomics 35, 610-612 (1996).
14. Borg, A. et al. Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br. J. Cancer 63, 136-142 (1991).
15. Courjal, F. et al. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. Cancer Res. 57, 4360-4367 (1997).
16. Allred, D.C. et al. Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance. Arch. Surg. 125, 107-113 (1990).
17. Molino, A. et al. Prognostic significance of estrogen receptors in 405 primary breast cancers: a comparison of immunohistochemical and biochemical methods. Breast Cancer Res. Treat. 45, 241-249 (1997).
18. Battifora, H. The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. Lab. Invest. 55, 244-248 (1986).
19. Battifora, H. & Mehta, P. The checkerboard tissue block. An improved multitissue control block. Lab. Invest. 63, 722-724 (1990).
20. Press, M.F., Hung, G., Godolphin, W. & Slamon, D.J. Sensitivity of HER-2/neu antibodies in archival tissue samples: potentialsource of error in immunohistochemical studies of oncogene expression. Cancer Res. 54, 2771-2777 (1994).